
Icosapent
All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate. — ChEBI
- IUPAC 명칭
- (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
- 분자식
- C20H30O2
- 분자량
- 302.5 g/mol
- 정확한 질량
- 302.224580195 Da
- XLogP3
- 5.6
- 위상 극성 표면적
- 37.3 Ų
- 수소 결합 공여체
- 1
- 수소 결합 수용체
- 2
- 공유결합 단위
- 1
- 정의된 입체중심
- 0
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEBI:CHEBI:28364
- ChEMBL:CHEMBL460026
- EPA DTXSID:DTXSID9041023
- PubMed:29968805
- PubMed:21683321
- PubMed:20671299
- PubMed:15753205
- PubMed:15619630
- PubMed:15519495
- PubMed:11347965
추가 과학 데이터베이스의 근거
EMBL-EBI ChEBI
all-cis-5,8,11,14,17-icosapentaenoic acid
An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.
- 처방
- C20H30O2
- 평균 질량
- 302.458 g/mol
- 단일 동위원소 질량
- 302.22458 Da
- 형식 전하
- 0
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- cardiovascular drug — has role (CHEBI:35554)
- anticonvulsant — has role (CHEBI:35623)
- anti-inflammatory agent — has role (CHEBI:67079)
- gastrointestinal drug — has role (CHEBI:55324)
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- all-cis-5,8,11,14,17-icosapentaenoate — is conjugate acid of (CHEBI:58562)
- 11421736 출처: PubMed
- 12549599 출처: PubMed
- 16643058 출처: PubMed
- 17420205 출처: PubMed
- 18459759 출처: PubMed
- 18638380 출처: PubMed
- 19036594 출처: PubMed
- 19054597 출처: PubMed
- 20014752 출처: PubMed
- 21118482 출처: PubMed
- 21274596 출처: PubMed
- 21903399 출처: PubMed
- 22260081 출처: PubMed
- 22822908 출처: PubMed
- 23920312 출처: PubMed
- 24108131 출처: PubMed
- 24238887 출처: PubMed
- 24351031 출처: PubMed
- 24387137 출처: PubMed
- 24389665 출처: PubMed
- 26784936 출처: PubMed
- 31483660 출처: PubMed
- 31618024 출처: PubMed
- 33378197 출처: PubMed
추가 선별 명칭
이 출처의 상호 참조
- CAS: 10417-94-4 — KEGG COMPOUND
- CAS: 10417-94-4 — ChemIDplus
- REGISTRY_NUMBER: 1714433 — Reaxys
- MANUAL_X_REF: 3174 — DrugCentral
- MANUAL_X_REF: C00000408 — KNApSAcK
- MANUAL_X_REF: C00001215 — KNApSAcK
- MANUAL_X_REF: C06428 — KEGG COMPOUND
- MANUAL_X_REF: D08061 — KEGG DRUG
- MANUAL_X_REF: DB00159 — DrugBank
- MANUAL_X_REF: EICOSAPENTAENOATE — MetaCyc
- MANUAL_X_REF: EPA — PDBeChem
- MANUAL_X_REF: HMDB0001999 — HMDB
- MANUAL_X_REF: LMFA01030759 — LIPID MAPS
매핑 기준: Exact CAS cross-reference in the ChEBI compound record. 출처 업데이트: 2018-03-05. 가져온 시각: 2026-08-31. 출처 기록 열기
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- LogP: 6.1 출처: DrugBank
- Physical Description: Liquid 출처: Human Metabolome Database (HMDB)
- Signal: Danger 출처: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] 출처: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기
과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.
추가 출처 적용 범위 및 일치 상태
| 출처 | 결과 | 확인됨 |
|---|---|---|
| EMBL-EBI ChEBI | 정확히 일치 | 2026-08-31 |
| NIH PubChem PUG-View | 정확히 일치 | 2026-08-31 |
기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.